BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 24082147)

  • 1. STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor.
    Wang Y; van Boxel-Dezaire AH; Cheon H; Yang J; Stark GR
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16975-80. PubMed ID: 24082147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.
    Gao SP; Mark KG; Leslie K; Pao W; Motoi N; Gerald WL; Travis WD; Bornmann W; Veach D; Clarkson B; Bromberg JF
    J Clin Invest; 2007 Dec; 117(12):3846-56. PubMed ID: 18060032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism.
    Stross C; Radtke S; Clahsen T; Gerlach C; Volkmer-Engert R; Schaper F; Heinrich PC; Hermanns HM
    J Biol Chem; 2006 Mar; 281(13):8458-68. PubMed ID: 16459330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.
    Pietrangelo A; Dierssen U; Valli L; Garuti C; Rump A; Corradini E; Ernst M; Klein C; Trautwein C
    Gastroenterology; 2007 Jan; 132(1):294-300. PubMed ID: 17241879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling.
    Fiebelkow J; Guendel A; Guendel B; Mehwald N; Jetka T; Komorowski M; Waldherr S; Schaper F; Dittrich A
    Cell Commun Signal; 2021 Sep; 19(1):94. PubMed ID: 34530865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.
    Wiejak J; Dunlop J; Mackay SP; Yarwood SJ
    Biochem J; 2013 Sep; 454(2):283-93. PubMed ID: 23782265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
    J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting.
    Zanders L; Kny M; Hahn A; Schmidt S; Wundersitz S; Todiras M; Lahmann I; Bandyopadhyay A; Wollersheim T; Kaderali L; Luft FC; Birchmeier C; Weber-Carstens S; Fielitz J
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):713-727. PubMed ID: 34821076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis.
    Liu X; Croker BA; Campbell IK; Gauci SJ; Alexander WS; Tonkin BA; Walsh NC; Linossi EM; Nicholson SE; Lawlor KE; Wicks IP
    Arthritis Rheumatol; 2014 Sep; 66(9):2391-402. PubMed ID: 24839265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dissection of gp130-dependent pathways in hepatocytes during liver regeneration.
    Dierssen U; Beraza N; Lutz HH; Liedtke C; Ernst M; Wasmuth HE; Trautwein C
    J Biol Chem; 2008 Apr; 283(15):9886-95. PubMed ID: 18216023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis.
    Fischer P; Hilfiker-Kleiner D
    Basic Res Cardiol; 2007 Jul; 102(4):279-97. PubMed ID: 17530315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway.
    Chen X; Yang W; Deng X; Ye S; Xiao W
    Mol Vis; 2020; 26():517-529. PubMed ID: 32818015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system.
    Sriuranpong V; Park JI; Amornphimoltham P; Patel V; Nelkin BD; Gutkind JS
    Cancer Res; 2003 Jun; 63(11):2948-56. PubMed ID: 12782602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
    Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric Crohn disease.
    Willson TA; Kuhn BR; Jurickova I; Gerad S; Moon D; Bonkowski E; Carey R; Collins MH; Xu H; Jegga AG; Guthery SL; Denson LA
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):32-43. PubMed ID: 22197944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall remodeling.
    Singh NK; Wang D; Kundumani-Sridharan V; Van Quyen D; Niu J; Rao GN
    J Biol Chem; 2011 Jun; 286(25):22478-88. PubMed ID: 21536676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line.
    Komyod W; Böhm M; Metze D; Heinrich PC; Behrmann I
    Mol Cancer Res; 2007 Mar; 5(3):271-81. PubMed ID: 17374732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosis.
    Carow B; Reuschl AK; Gavier-Widén D; Jenkins BJ; Ernst M; Yoshimura A; Chambers BJ; Rottenberg ME
    PLoS Pathog; 2013; 9(7):e1003442. PubMed ID: 23853585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.